| Literature DB >> 29206470 |
Tourin Bzeih1,2, Diana Lamaa1, Gilles Frison3, Ali Hachem2, Nada Jaber2, Jerome Bignon4, Pascal Retailleau4, Mouad Alami1, Abdallah Hamze1.
Abstract
A novel, sequential, palladium-catalyzed, cross-coupling reaction using N-tosylhydrazone and bromonitrobenzene derivatives followed by reductive cyclization has been developed. This transformation providing an efficient route to unexpected N-arylindole derivatives involves, in a one-pot reaction, the formation of one Csp2-Csp2 bond and two Csp2-N bonds together with the cleavage of one Csp2-heteroatom bond. Evaluation of the biological activity led to the identification of compound 5a, which displays potent activity at nanomolar concentrations against human colon carcinoma cell line.Entities:
Year: 2017 PMID: 29206470 DOI: 10.1021/acs.orglett.7b03422
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005